Treatment

IAM1363 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
This study is testing a new medicine called IAM1363 for advanced cancers with a specific change called HER2. It aims to find a safe and effective dose, including for breast, lung, and stomach cancers that have spread to the brain.
For: HER2 Mutation-Related Tumors · HER2 · HER2-positive Breast Cancer
United States · France · Ireland